Kinome Profiling in Pediatric Brain Tumors as a New Approach for Target Discovery
Open Access
- 15 July 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (14), 5987-5995
- https://doi.org/10.1158/0008-5472.can-08-3660
Abstract
Progression in pediatric brain tumor growth is thought to be the net result of signaling through various protein kinase-mediated networks driving cell proliferation. Defining new targets for treatment of human malignancies, without a priori knowledge on aberrant cell signaling activity, remains exceedingly complicated. Here, we introduce kinome profiling using flow-through peptide microarrays as a new concept for target discovery. Comprehensive tyrosine kinase activity profiles were identified in 29 pediatric brain tumors using the PamChip kinome profiling system. Previously reported activity of epidermal growth factor receptor, c-Met, and vascular endothelial growth factor receptor in pediatric brain tumors could be appreciated in our array results. Peptides corresponding with phosphorylation consensus sequences for Src family kinases showed remarkably high levels of phosphorylation compared with normal tissue types. Src activity was confirmed applying Phos-Tag SDS-PAGE. Furthermore, the Src family kinase inhibitors PP1 and dasatinib induced substantial tumor cell death in nine pediatric brain tumor cell lines but not in control cell lines. Thus, this study describes a new high-throughput technique to generate clinically relevant tyrosine kinase activity profiles as has been shown here for pediatric brain tumors. In the era of a rapidly increasing number of small-molecule inhibitors, this approach will enable us to rapidly identify new potential targets in a broad range of human malignancies. [Cancer Res 2009;69(14):5987–95]Keywords
Other Versions
This publication has 42 references indexed in Scilit:
- The Protein Phosphatase Activity of PTEN Regulates Src Family Kinases and Controls Glioma MigrationCancer Research, 2008
- Evidence for a Minimal Eukaryotic Phosphoproteome?PLOS ONE, 2007
- Protein-Tyrosine Kinase Activity Profiling in Knock Down Zebrafish EmbryosPLOS ONE, 2007
- Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitroBreast Cancer Research and Treatment, 2007
- Mutational analysis of PDGFR–RAS/MAPK pathway activation in childhood medulloblastomaEuropean Journal Of Cancer, 2006
- Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non–Small Cell Lung Cancer CellsClinical Cancer Research, 2005
- Platelet-derived growth factor-B and -C and active α-receptors in medulloblastoma cellsBiochemical and Biophysical Research Communications, 2002
- Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylationOncogene, 1998
- CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASESAnnual Review of Cell and Developmental Biology, 1997
- The wee1 protein kinase is required for radiation-induced mitotic delayNature, 1992